EP2007329A1 - Nasal dilator - Google Patents

Nasal dilator

Info

Publication number
EP2007329A1
EP2007329A1 EP07732342A EP07732342A EP2007329A1 EP 2007329 A1 EP2007329 A1 EP 2007329A1 EP 07732342 A EP07732342 A EP 07732342A EP 07732342 A EP07732342 A EP 07732342A EP 2007329 A1 EP2007329 A1 EP 2007329A1
Authority
EP
European Patent Office
Prior art keywords
nasal dilator
limbs
limb
dilator
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP07732342A
Other languages
German (de)
French (fr)
Other versions
EP2007329B1 (en
Inventor
Keith Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP2007329A1 publication Critical patent/EP2007329A1/en
Application granted granted Critical
Publication of EP2007329B1 publication Critical patent/EP2007329B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/01Orthopaedic devices, e.g. splints, casts or braces
    • A61F5/08Devices for correcting deformities of the nose ; Devices for enlarging the nostril, e.g. for breathing improvement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56Devices for preventing snoring

Definitions

  • the present invention relates to a nasal dilator, in particular but not exclusively, to nasal dilators that can improve inhalation and exhalation through the nose and thereby alleviate problems associated with chronic or temporary nasal congestion. Additionally, the invention relates to methods of inserting the nasal dilator into the nose and the treatment of chronic or temporary nasal congestion.
  • Mucus is a viscous colloid made by goblet cells in the mucous membranes of the nose.
  • Mucus contains antiseptic enzymes (such as lysozyme), immunoglobulins, mucins and inorganic salts suspended in water.
  • antiseptic enzymes such as lysozyme
  • immunoglobulins such as lysozyme
  • mucins mucins
  • Mucus In the respiratory system, it catches foreign matter and tries to prevent it from entering the body.
  • Mucus is normally secreted in only one nostril at a time, and the nostril secreting the mucus changes about every 4 to 6 hours.
  • mucus has important physiological functions, abnormally increased mucus production in the respiratory tract is problematic and is a symptom of many common diseases, such as the common cold.
  • the presence of mucus in the nose and throat is normal, but increased quantities can impede comfortable breathing.
  • Nasal congestion is the blockage of the nasal passages and is usually due to excessive secretion of mucus. As mucus is usually secreted in one nostril at a time, it is normal to have only a single nostril blocked at any one time. Nasal congestion has many causes and can range from a mild annoyance to a life-threatening condition. Nasal congestion can interfere with the ears, hearing, and speech development.
  • Significant congestion may interfere with sleep, cause snoring, can be associated with sleep apnea, can result in insufficient oxygen levels and hypoxia, as well as right- sided heart failure.
  • a blocked nose can also causes mild facial and head pain.
  • the anatomical structure of the human nose contributes to the difficulties experienced when breathing.
  • the lower internal portion of each nostril known as the vestibule
  • the ostium internum which defines the opening of the nasal air passage defined by the isthmus nasi (running from 1.65 to 2.65 cm from the nostril, and is typically about 0.3 cm in diameter). It is this narrowed portion of the nose that can become blocked with mucus.
  • the ostium internum (located about 1 to 1.5cm from the nostril) is an orifice whose pear-shaped format, visualized under anterior rhinoscopy, is laterally limited by the inferior border of lateral superior cartilage, medially to the nasal septum and inferiorly to the floor of the nasal cavity.
  • Chemical decongestants such as pseudoephidrine and oxymetazoline, are commonly used to clear nasal decongestion. These chemicals work by reducing inflammation of the nasal cavity and acting as vasoconstrictors. However, where possible, it is not desirable to use such chemical interventions as they can be associated with harmful side affects.
  • Cage or stent like devices have also been used to combat nasal decongestion, see for example US Patent No. 4,414,977.
  • Such devices work by acting as fixed volume dilators and are placed inside the nostril.
  • these dilators are not capable of expanding the breadth of the nasal cavity passed the fixed volume, are uncomfortable to wear, and difficult to retrieve after use.
  • Nasal dilators are known that include a pair of outwardly biased opposing limbs that are designed for inserting one limb into each nostril (see, for example,
  • a nasal dilator comprising at least two opposing limbs that are biased apart and that are configured so as to be capable of being inserted simultaneously into a single nostril.
  • a dilator inserting such a dilator into the nostril of the nasal passage that is unblocked can provide the optimum dilation of the nasal passage that cannot be achieved by a dilator that, for example, dilates both nasal passages simultaneously. Dilation of the soft tissue of the vestibule does not provide any benefit so the nasal dilator is preferably configured such that once both limbs are inserted they may perform an outward dilation of the nostril at the soft tissue surrounding the ostium internum.
  • one of the simplest ways in which to construct such a dilator is by connecting the opposing limbs by a resiliently deformable bridge. Such a construction may be created by moulding (e.g. injection moulding) the device so as to leave the mould with the at least two opposing limbs connected by a resiliently deformable bridge configuration.
  • the dilator is arranged such that the deformable bridge is adjacent an end of each limb.
  • the limbs extend from the bridge in substantially the same direction.
  • the limbs diverge as they extend away from the bridge. Divergence of the limbs ensures the optimum dilation of the nasal passage without extending the nostril entrance.
  • the dilator may be formed from a length of material comprising a notch, around which the length of material may be bent so as to form the resiliently deformable bridge.
  • the length of material extending from the notch defining the limbs.
  • the thickness of the limbs taper from the thickest point at the bridge.
  • the diameter of each limb at its thickest point is less than 0.3, 0.25, 0.2 or 0.1 cm.
  • All limbs are preferably of equal length, and so maintain equal pressure on the nasal cavity from each limb and so prevent any torsional forces.
  • each limb is preferably more than 1, 1.5, 2 or 2.5 cm in length.
  • the nasal dilator further comprises a cushioned portion provided on each limb.
  • the cushioned portions may be provided at or towards the end of each limb that is furthest removed from the bridge. It has been found that cushioned portions that mould or are shaped to the contours of the nasal cavity are most comfortable, for example concaved pads. Concaved pads are preferred as they match the contours of the nasal cavity and provide only limited obstruction to the airway.
  • the cushioned portions may be provided directly onto the limbs or may provided on a stalk that laterally extends from the end of the limb that is furthest removed from the bridge. The stalk may be off reduced thickness to the rest of the limb so that the outer surface of the limb and the cushioned portion can be continuous.
  • the cushioned portion maybe sleeves.
  • the cushioned portions may be bonded to the stalks or limbs or maybe moulded onto the stalks or limbs.
  • the stalks or limbs may include a projecting portion to retain the cushioned pads thereon.
  • the dilator may include at least one stop means associated with at least one limb and configured such that the dilator cannot be inserted into the nasal cavity passed the stop means.
  • the stop means preferably extends laterally from at least one limb.
  • the stop means may alternatively be formed by at least one laterally extending kink in the at least one limb. In such a confirmation the bend or kink along the otherwise substantially straight limb can block the insertion of the dilator passed the kink in the limb.
  • Two kinks may be provided on one limb with a finger grip portion defined by the portion of the limb provided between the kinks.
  • the stop means may also act as a finger grip portion.
  • the stop means may be formed integrally with at least one limb.
  • the stop means preferably extends more than 1 cm from the limb, or the kink extends more than 1 cm from the line of the limb. It is preferred that each limb extends more than 1.5, 2 or 2.5 cm from the stop means to the end of each limb that is furthest removed from the bridge. Preferably the same stop means is provided in all limbs.
  • An alternative or additional safety feature that could be included in the present invention is an elbow bend in at least one limb. Such a bend in the limb prevents the insertion of the dilator passed the point in the limb of the bend.
  • the elbow defines an angle in the limb of substantially 90° and/or the same elbow bend is provided in all limbs.
  • the dilator in order to spread the outward pressure from the dilator and optimise the dilation of the nasal cavity the dilator may be provided with a plurality of limbs, for example, 2, 3, 4, 5 or more limbs.
  • the limbs are preferably equally biased away from each other.
  • Embodiments of the present invention may be configured for use during the day, when a device extending from the nose is not desired, for cosmetic reasons.
  • the limbs and resiliently deformable bridge may be configured, when in use, so as to be entirely housed within the nasal cavity.
  • Such configurations may be achieved in a number of ways, however, the inventor has found the following two embodiments to be particularly effective.
  • the resiliently deformable bridge may take the form of a horse shoe with each limb extending in a perpendicular manner therefrom.
  • the horse shoe shaped bridge may be shaped so as to mirror the shape of the internal nasal cavity.
  • the resiliently deformable bridge may be formed from a first and second resiliently deformable u-bend that are connected by a third resiliently deformable u-bend, wherein the third resiliently deformable u-bend is inverted in relation to the first and second deformable u-bends, i.e. the resiliently deformable bridge takes a "M" shape.
  • the nasal dilator may comprise a passageway through which air can flow.
  • the passageway may be associated with the nasal dilator in a number of ways, for example, the passageway can be associated with a limb from the bridge or attached directly to the bridge.
  • the passageway may be a tubular member. Such a tubular member can be moveably retained on a limb.
  • the passageway can be rotatably mounted and/or made of a flexible material and/or a mesh.
  • the limb associated with the passageway may extend further from the bridge than the other limbs.
  • it preferably includes a mesh provided at its end furthest removed from the bridge.
  • the dilator should be made of a light material so that it may be easily worn in the nose without causing any discomfort.
  • the nasal dilator is preferably less than 1, 0.5 or 0.25 g in weight.
  • the nasal dilator may be made from synthetic plastics, such as nylon, polyethylene, polypropylene, or any combination thereof. Such a dilator can be cheaply made by integral moulding.
  • the nasal dilator comprises acetal, most preferably medical grade acetal.
  • Acetal is advantageous because it has good shape memory and nasal dilators of specific tensions can be manufactured. Acetal is also very resistant to bending fatigue.
  • the nasal dilator comprises polycarbonate.
  • Polycarbonate lends itself to being adjusted by the user to a preferred tension.
  • the dilator is preferably disposable.
  • a method of inserting a nasal dilator comprising the steps of urging together opposing limbs of a dilator that comprises at least two biased apart limbs so as to reduce the profile of the dilator, passing all limbs of the reduced profile dilator in through a single nostril, and releasing the limbs such that they spring apart providing an outward dilation of the single nostril.
  • the dilator is preferably passed through the nostril until they may perform an outward dilation of the nostril at the soft tissue surrounding the ostium internum. Preferably, there are two limbs.
  • the step of passing the limbs in through a single nostril comprises inserting the limbs such that a plane through the limbs is substantially parallel to the nasal septum.
  • the step of passing the limbs in through a single nostril comprises rotating the nasal dilator such that the plane through the limbs is substantially perpendicular to the septum.
  • the limbs Preferably, once the limbs are released the limbs outwardly dilate a side of the nostril away from the septum.
  • the method may include a first step of locating the unblocked nostril for inserting the dilator into. This can simply be achieved by the user closing one nostril and exhaling through the open nostril, if exhalation is difficult then the open nostril is congested. Alternatively, the method may involve inserting one dilator into each nostril.
  • the method may be used to maintain an open airway and may therefore make it easier for the user to achieve the state of sleep.
  • the method may be used to treat nasal congestion.
  • the dilator used in the second aspect of the present invention is any one of the dilators described in the first aspect of the present invention. It will be understood that any of the features of the first aspect may be applicable to the second aspect and are not repeated for brevity.
  • Figure 1 shows an embodiment of the present invention with two limbs.
  • Figure 2 shows an embodiment of the present invention with three limbs.
  • Figure 3 shows an embodiment of the present invention with two non-linear limbs.
  • Figure 4 shows an embodiment of the present invention with three non-linear limbs.
  • Figure 5 shows an embodiment of the present invention with an elbow bend.
  • Figure 6 shows an embodiment of the present invention with a horse shoe shaped resiliently deformable bridge.
  • Figure 7 shows an embodiment of the present invention with an "M" shaped resiliently deformable bridge.
  • Figure 8 shows an embodiment of the present invention with a passageway through which air may flow.
  • Figure 9 shows an embodiment of the present invention with combined spars and grip portions.
  • Figure 10 shows an embodiment of the present invention with a notched bridge.
  • Figure 11 shows an embodiment of the present invention with a reduced profile.
  • the nasal dilator of the present invention as illustrated in Figure 1, comprises a pair of opposing limbs (1) that are connected by a resiliently deformable bridge (2).
  • a spar (3) extends laterally from each limb (1) and concave pads (4) are provided at the end of each limb (1) that is furthest removed from the bridge (2).
  • the spars (3) engage with the outer portion of the nostril during insertion of the dilator into the nostril, thereby preventing insertion passed the point on the limb (1) from where the spars (3) extend.
  • a further embodiment of the nasal dilator of the present invention can be seen in Figure 2. This embodiment is similar to the embodiment shown in figure 1, but has three limbs (1). Each limb (1) is equally biased, and so spaced, apart.
  • each limb includes two kinks (5) at the portion of each limb that is closest to the bridge (2). Between these kinks (5) is defined a grip portion
  • the user may grip the dilator between two fingers, each finger resting in the grip portion (6).
  • the kinks (5) engage with the outer portion of the nostril during insertion of the dilator into the nostril, thereby preventing insertion passed the point on the limb (1) from where the kink (5) that is furthest removed from the bridge (2) is formed.
  • FIG. 4 A further embodiment of the nasal dilator of the present invention can be seen in Figure 4.
  • This embodiment is similar to the embodiment shown in figure 3, but has three limbs (1). Each limb (1) is equally biased, and so spaced, apart.
  • the limbs (1) include identical 90 degree bends (7) in the portion of each limb (1) towards the bridge (2).
  • the limbs (1) include protrusions (8) that laterally extend from the end of each limb (1) that is furthest removed from the bridge (2).
  • the protrusions (8) laterally extend away from the protrusion (8) on the opposing limb (1).
  • Concave pads are provided at the end of each lateral protrusion.
  • the bridge (2) engages with the outer portion of the nostril during insertion of the dilator into the nostril, thereby preventing insertion passed the 90 degree bend (7).
  • the outward bias of the limbs (1) urges the concave pads (4) towards the soft tissue within the nasal cavity that surrounds the ostium internum.
  • FIG. 6 A further embodiment of the nasal dilator of the present invention can be seen in Figure 6.
  • the deformable bridge (2) is not formed from a u- bend, like earlier embodiments, but is instead provided in the shape of a horse shoe.
  • a limb (1) extends in a perpendicular manner from the horse shoe shaped bridge (2) at each of the portions provided towards the free ends of the horse shoe (2).
  • the horse shoe bridge (2) is. resilien y deformable, in use, it may be squeezed between two fingers, thereby narrowing the profile of the horse shoe (2) and bringing the limbs (1) closer together. In such a squeezed configuration, the dilator may easily pass entirely into the nasal cavity.
  • the bridge (2) When the pressure applied to the bridge (2) is removed, once the dilator has been inserted into the nasal cavity, the bridge (2) is able to return to its original shape which conforms to the shape of the interior of the nasal cavity and the outward bias of the limbs (1) urges the concave pads (4) towards the soft tissue within the nasal cavity that surrounds the ostium internum.
  • FIG. 7 A further embodiment of the nasal dilator of the present invention can be seen in Figure 7.
  • the deformable bridge (2) is formed from a first and second resiliently deformable u-bend (9)that are connected by a third resiliently deformable u-bend (10), which is inverted in relation to the first and second deformable bridge (10).
  • the bridge (2) takes the form of an "M”.
  • the configurations permit the dilator to be entirely housed within the nasal cavity.
  • FIG. 8 A further embodiment of the nasal dilator of the present invention can be seen in Figure 8.
  • This embodiment is similar to the embodiment illustrated in Figure 3, but includes a longer limb (11) that extends further than the other two limbs (1).
  • This longer limb (11) includes a tube (12) rotatably mounted around a portion of the longer limb (11).
  • the tube (12) is made from a mesh.
  • the dilator can be inserted into the nostril in much the same manner as described for Figure 3 above, however, the third limb (11) is inserted passed the ostium internum and into the isthmus nasi. When inserted, the tube is positioned in the isthmus nasi and forces the walls of this cavity apart thereby defining a passageway through which air can travel.
  • the longer limb (11) and the tube (12) are flexible, enabling them to be configured to the shape of the nasal passageway.
  • the tube (12) can move longitudinally and rotate on the third limb (11) so as to be positioned in at the appropriate position along the longer limb (11).
  • FIG 9 shows a still further embodiment of the present invention with combined spars (3) and grip portions (18).
  • each limb (1) defines a reduced lower limb section (Ia, shown in broken outline) over which cushioned sleeves (20) can be positioned.
  • the cushioned sleeves (20) are moulded out of a soft elastomer and are bonded to the reduced limb sections (Ia) to provide a continuous outer limb surface (22).
  • the cushioned sleeves (20) define a rounded end (24) to assist in easing the dilator into the nasal cavity with minimum discomfort to the wearer.
  • Figure 10 shows an embodiment of the present invention with a notched bridge (2).
  • the bridge (2) of the dilator bends around a notch (26) located at the midpoint of the bridge (2).
  • the bridge (2) also includes opposing kinks (5) which prevent over insertion over the dilator into the nasal cavity.
  • the kinks (5) also define grip portions (18).
  • the lower ends of the reduced limb portions (Ia) define projections (28).
  • cushioned sleeves (20) are moulded over the lower limb portions (Ia), the projections (28) being provided to prevent the cushioned sleeves (20) from slipping off.
  • Figure 11 shows an embodiment of the present invention with a reduced profile. In this embodiment, the bridge (2) is fairly flat so that the dilator can be inserted fully into the nose and worn more discreetly.
  • the user When using the above devices, the user will first determine which one of the nasal passageways that is blocked by physically closing one nostril by pinching it with ones fingers and exhaling through the remaining open nasal passageway. If it is difficult to exhale through the open passageway then this passageway is congested. If exhalation is easy then this is the nostril in which the dilator is to be inserted in the above mentioned manner.

Landscapes

  • Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

A nasal dilator is described. The nasal dilator comprises at least two opposing limbs (1) that are biased apart and that are configured so as to be capable of being inserted simultaneously into a single nostril. In one embodiment, the dilator comprises two limbs and the limbs are configured such that once both limbs are inserted they may perform an outward dilation of the nostril at the soft tissue surrounding the ostium internum.

Description

Nasal Dilator
Field of the Invention
The present invention relates to a nasal dilator, in particular but not exclusively, to nasal dilators that can improve inhalation and exhalation through the nose and thereby alleviate problems associated with chronic or temporary nasal congestion. Additionally, the invention relates to methods of inserting the nasal dilator into the nose and the treatment of chronic or temporary nasal congestion.
Background to the Invention
Mucus is a viscous colloid made by goblet cells in the mucous membranes of the nose. Mucus contains antiseptic enzymes (such as lysozyme), immunoglobulins, mucins and inorganic salts suspended in water. In the respiratory system, it catches foreign matter and tries to prevent it from entering the body. Mucus is normally secreted in only one nostril at a time, and the nostril secreting the mucus changes about every 4 to 6 hours. Although the secretion of mucus has important physiological functions, abnormally increased mucus production in the respiratory tract is problematic and is a symptom of many common diseases, such as the common cold. The presence of mucus in the nose and throat is normal, but increased quantities can impede comfortable breathing.
Nasal congestion is the blockage of the nasal passages and is usually due to excessive secretion of mucus. As mucus is usually secreted in one nostril at a time, it is normal to have only a single nostril blocked at any one time. Nasal congestion has many causes and can range from a mild annoyance to a life-threatening condition. Nasal congestion can interfere with the ears, hearing, and speech development.
Significant congestion may interfere with sleep, cause snoring, can be associated with sleep apnea, can result in insufficient oxygen levels and hypoxia, as well as right- sided heart failure. A blocked nose can also causes mild facial and head pain.
The anatomical structure of the human nose contributes to the difficulties experienced when breathing. Specifically, the lower internal portion of each nostril, known as the vestibule, typically tapers inward to a narrowed area, known as the ostium internum, which defines the opening of the nasal air passage defined by the isthmus nasi (running from 1.65 to 2.65 cm from the nostril, and is typically about 0.3 cm in diameter). It is this narrowed portion of the nose that can become blocked with mucus. The ostium internum (located about 1 to 1.5cm from the nostril) is an orifice whose pear-shaped format, visualized under anterior rhinoscopy, is laterally limited by the inferior border of lateral superior cartilage, medially to the nasal septum and inferiorly to the floor of the nasal cavity. Chemical decongestants, such as pseudoephidrine and oxymetazoline, are commonly used to clear nasal decongestion. These chemicals work by reducing inflammation of the nasal cavity and acting as vasoconstrictors. However, where possible, it is not desirable to use such chemical interventions as they can be associated with harmful side affects.
Cage or stent like devices have also been used to combat nasal decongestion, see for example US Patent No. 4,414,977. Such devices work by acting as fixed volume dilators and are placed inside the nostril. However, these dilators are not capable of expanding the breadth of the nasal cavity passed the fixed volume, are uncomfortable to wear, and difficult to retrieve after use.
Nasal dilators are known that include a pair of outwardly biased opposing limbs that are designed for inserting one limb into each nostril (see, for example,
British Patent Publication No. 2 330 079). Such devices expand the outermost fleshy portion of the vestibule of the nose which can be uncomfortable and may result in a transient or even permanent stretching of that tissue, which can be undesirable for cosmetic reasons. Additionally, as both nostrils are being dilated at the same time, each nostril cannot be optimally dilated. There is a finite amount of tissue forming the nostril, which is capable of a finite amount of stretch, and so if both nostrils are being stretched in two opposing directions optimum dilation of each nostril is not possible.
Summary of the Invention
It is therefore an object of the invention to provide a nasal dilator that is capable of alleviating breathing problems associated with nasal congestion, but that does not possess the problems associated with the prior art, as discussed above.
According to a first aspect of the present invention there is provided a nasal dilator comprising at least two opposing limbs that are biased apart and that are configured so as to be capable of being inserted simultaneously into a single nostril.
It has surprisingly been found that inserting such a dilator into the nostril of the nasal passage that is unblocked can provide the optimum dilation of the nasal passage that cannot be achieved by a dilator that, for example, dilates both nasal passages simultaneously. Dilation of the soft tissue of the vestibule does not provide any benefit so the nasal dilator is preferably configured such that once both limbs are inserted they may perform an outward dilation of the nostril at the soft tissue surrounding the ostium internum. The applicant has found that one of the simplest ways in which to construct such a dilator is by connecting the opposing limbs by a resiliently deformable bridge. Such a construction may be created by moulding (e.g. injection moulding) the device so as to leave the mould with the at least two opposing limbs connected by a resiliently deformable bridge configuration. Preferably, the dilator is arranged such that the deformable bridge is adjacent an end of each limb.
Preferably, the limbs extend from the bridge in substantially the same direction.
Most preferably, the limbs diverge as they extend away from the bridge. Divergence of the limbs ensures the optimum dilation of the nasal passage without extending the nostril entrance.
Alternatively, the dilator may be formed from a length of material comprising a notch, around which the length of material may be bent so as to form the resiliently deformable bridge. In one embodiment, the length of material extending from the notch defining the limbs. Such simple constructions have the advantage of being cheap and easy to manufacture.
In order to configure the dilator so as to be inserted easily into the nose it is preferred that the thickness of the limbs taper from the thickest point at the bridge. Preferably the diameter of each limb at its thickest point is less than 0.3, 0.25, 0.2 or 0.1 cm. All limbs are preferably of equal length, and so maintain equal pressure on the nasal cavity from each limb and so prevent any torsional forces. The applicant has found that in order for the limbs to extend a sufficient distance into the nasal cavity so as to dilate the tissue around the ostium internum each limb is preferably more than 1, 1.5, 2 or 2.5 cm in length. For comfort of the user it is also preferred that the nasal dilator further comprises a cushioned portion provided on each limb. The cushioned portions may be provided at or towards the end of each limb that is furthest removed from the bridge. It has been found that cushioned portions that mould or are shaped to the contours of the nasal cavity are most comfortable, for example concaved pads. Concaved pads are preferred as they match the contours of the nasal cavity and provide only limited obstruction to the airway. The cushioned portions may be provided directly onto the limbs or may provided on a stalk that laterally extends from the end of the limb that is furthest removed from the bridge. The stalk may be off reduced thickness to the rest of the limb so that the outer surface of the limb and the cushioned portion can be continuous. The cushioned portion maybe sleeves. The cushioned portions may be bonded to the stalks or limbs or maybe moulded onto the stalks or limbs. The stalks or limbs may include a projecting portion to retain the cushioned pads thereon.
The applicant has found that it may be desirable to include a feature of the invention that prevents the device from being inhaled or pushed too far into the nas,al cavity. Thus, the dilator may include at least one stop means associated with at least one limb and configured such that the dilator cannot be inserted into the nasal cavity passed the stop means.
The stop means preferably extends laterally from at least one limb. The stop means may alternatively be formed by at least one laterally extending kink in the at least one limb. In such a confirmation the bend or kink along the otherwise substantially straight limb can block the insertion of the dilator passed the kink in the limb. Two kinks may be provided on one limb with a finger grip portion defined by the portion of the limb provided between the kinks. Alternatively, the stop means may also act as a finger grip portion. In the interests of cheap and efficient manufacture the stop means may be formed integrally with at least one limb. In order to provide the required blocking, the stop means preferably extends more than 1 cm from the limb, or the kink extends more than 1 cm from the line of the limb. It is preferred that each limb extends more than 1.5, 2 or 2.5 cm from the stop means to the end of each limb that is furthest removed from the bridge. Preferably the same stop means is provided in all limbs. An alternative or additional safety feature that could be included in the present invention is an elbow bend in at least one limb. Such a bend in the limb prevents the insertion of the dilator passed the point in the limb of the bend. Preferably the elbow defines an angle in the limb of substantially 90° and/or the same elbow bend is provided in all limbs.
The applicant has found that in order to spread the outward pressure from the dilator and optimise the dilation of the nasal cavity the dilator may be provided with a plurality of limbs, for example, 2, 3, 4, 5 or more limbs. The limbs are preferably equally biased away from each other. Embodiments of the present invention may be configured for use during the day, when a device extending from the nose is not desired, for cosmetic reasons. Thus, the limbs and resiliently deformable bridge may be configured, when in use, so as to be entirely housed within the nasal cavity. Such configurations may be achieved in a number of ways, however, the inventor has found the following two embodiments to be particularly effective. The resiliently deformable bridge may take the form of a horse shoe with each limb extending in a perpendicular manner therefrom. The horse shoe shaped bridge may be shaped so as to mirror the shape of the internal nasal cavity. Alternatively, the resiliently deformable bridge may be formed from a first and second resiliently deformable u-bend that are connected by a third resiliently deformable u-bend, wherein the third resiliently deformable u-bend is inverted in relation to the first and second deformable u-bends, i.e. the resiliently deformable bridge takes a "M" shape.
In a further preferred embodiment of the present invention, the nasal dilator may comprise a passageway through which air can flow. In this way, even if the dilator is inserted into a blocked nasal cavity the passageway may pass through the blockage and the limbs help to expand the area for the passageway to pass through. The passageway may be associated with the nasal dilator in a number of ways, for example, the passageway can be associated with a limb from the bridge or attached directly to the bridge. The passageway may be a tubular member. Such a tubular member can be moveably retained on a limb. In order to improve the ease in which such a dilator may be inserted the passageway can be rotatably mounted and/or made of a flexible material and/or a mesh. As the passageway may need to pass further into the nasal cavity than the opposed limbs, possibly even into the isthmus nasi, the limb associated with the passageway may extend further from the bridge than the other limbs. In order to prevent the passageway from becoming blocked, it preferably includes a mesh provided at its end furthest removed from the bridge.
The dilator should be made of a light material so that it may be easily worn in the nose without causing any discomfort. The nasal dilator is preferably less than 1, 0.5 or 0.25 g in weight. The nasal dilator may be made from synthetic plastics, such as nylon, polyethylene, polypropylene, or any combination thereof. Such a dilator can be cheaply made by integral moulding.
In a preferred embodiment, the nasal dilator comprises acetal, most preferably medical grade acetal. Acetal is advantageous because it has good shape memory and nasal dilators of specific tensions can be manufactured. Acetal is also very resistant to bending fatigue.
In an alternative embodiment, the nasal dilator comprises polycarbonate. Polycarbonate lends itself to being adjusted by the user to a preferred tension. In order to prevent the need to wash the dilator or risk the transfer of infection the dilator is preferably disposable.
In a second aspect of the present invention, there is provided a method of inserting a nasal dilator comprising the steps of urging together opposing limbs of a dilator that comprises at least two biased apart limbs so as to reduce the profile of the dilator, passing all limbs of the reduced profile dilator in through a single nostril, and releasing the limbs such that they spring apart providing an outward dilation of the single nostril.
The dilator is preferably passed through the nostril until they may perform an outward dilation of the nostril at the soft tissue surrounding the ostium internum. Preferably, there are two limbs.
Preferably, the step of passing the limbs in through a single nostril comprises inserting the limbs such that a plane through the limbs is substantially parallel to the nasal septum.
Preferably, the step of passing the limbs in through a single nostril comprises rotating the nasal dilator such that the plane through the limbs is substantially perpendicular to the septum.
Preferably, once the limbs are released the limbs outwardly dilate a side of the nostril away from the septum.
The method may include a first step of locating the unblocked nostril for inserting the dilator into. This can simply be achieved by the user closing one nostril and exhaling through the open nostril, if exhalation is difficult then the open nostril is congested. Alternatively, the method may involve inserting one dilator into each nostril.
The method may be used to maintain an open airway and may therefore make it easier for the user to achieve the state of sleep. The method may be used to treat nasal congestion.
Preferably the dilator used in the second aspect of the present invention is any one of the dilators described in the first aspect of the present invention. It will be understood that any of the features of the first aspect may be applicable to the second aspect and are not repeated for brevity.
Brief Description of the Drawings The present invention will now be described, by way of example, with reference to the accompanying drawings, in which:-
Figure 1 shows an embodiment of the present invention with two limbs. Figure 2 shows an embodiment of the present invention with three limbs. Figure 3 shows an embodiment of the present invention with two non-linear limbs.
Figure 4 shows an embodiment of the present invention with three non-linear limbs.
Figure 5 shows an embodiment of the present invention with an elbow bend. Figure 6 shows an embodiment of the present invention with a horse shoe shaped resiliently deformable bridge.
Figure 7 shows an embodiment of the present invention with an "M" shaped resiliently deformable bridge.
Figure 8 shows an embodiment of the present invention with a passageway through which air may flow. Figure 9 shows an embodiment of the present invention with combined spars and grip portions.
Figure 10 shows an embodiment of the present invention with a notched bridge.
Figure 11 shows an embodiment of the present invention with a reduced profile.
Detailed Description of the Drawings
The nasal dilator of the present invention, as illustrated in Figure 1, comprises a pair of opposing limbs (1) that are connected by a resiliently deformable bridge (2). A spar (3) extends laterally from each limb (1) and concave pads (4) are provided at the end of each limb (1) that is furthest removed from the bridge (2). In use, the spars (3) engage with the outer portion of the nostril during insertion of the dilator into the nostril, thereby preventing insertion passed the point on the limb (1) from where the spars (3) extend. A further embodiment of the nasal dilator of the present invention can be seen in Figure 2. This embodiment is similar to the embodiment shown in figure 1, but has three limbs (1). Each limb (1) is equally biased, and so spaced, apart.
A further embodiment of the nasal dilator of the present invention can be seen in Figure 3. This embodiment is similar to the embodiment shown in Figure 1, but instead of including a spar (3), each limb includes two kinks (5) at the portion of each limb that is closest to the bridge (2). Between these kinks (5) is defined a grip portion
(6) that is sized so as to be suitable to accommodate a finger tip. In use, the user may grip the dilator between two fingers, each finger resting in the grip portion (6). The kinks (5) engage with the outer portion of the nostril during insertion of the dilator into the nostril, thereby preventing insertion passed the point on the limb (1) from where the kink (5) that is furthest removed from the bridge (2) is formed.
A further embodiment of the nasal dilator of the present invention can be seen in Figure 4. This embodiment is similar to the embodiment shown in figure 3, but has three limbs (1). Each limb (1) is equally biased, and so spaced, apart.
A further embodiment of the nasal dilator of the present invention can be seen in Figure 5. In this embodiment the limbs (1) include identical 90 degree bends (7) in the portion of each limb (1) towards the bridge (2). The limbs (1) include protrusions (8) that laterally extend from the end of each limb (1) that is furthest removed from the bridge (2). The protrusions (8) laterally extend away from the protrusion (8) on the opposing limb (1). Concave pads are provided at the end of each lateral protrusion. In use, the portion of the limb (1) that extends from the 90 degree bend
(7) to the bridge (2) engages with the outer portion of the nostril during insertion of the dilator into the nostril, thereby preventing insertion passed the 90 degree bend (7). In use the outward bias of the limbs (1) urges the concave pads (4) towards the soft tissue within the nasal cavity that surrounds the ostium internum.
A further embodiment of the nasal dilator of the present invention can be seen in Figure 6. In this embodiment the deformable bridge (2) is not formed from a u- bend, like earlier embodiments, but is instead provided in the shape of a horse shoe. A limb (1) extends in a perpendicular manner from the horse shoe shaped bridge (2) at each of the portions provided towards the free ends of the horse shoe (2). As the horse shoe bridge (2) is. resilien y deformable, in use, it may be squeezed between two fingers, thereby narrowing the profile of the horse shoe (2) and bringing the limbs (1) closer together. In such a squeezed configuration, the dilator may easily pass entirely into the nasal cavity. When the pressure applied to the bridge (2) is removed, once the dilator has been inserted into the nasal cavity, the bridge (2) is able to return to its original shape which conforms to the shape of the interior of the nasal cavity and the outward bias of the limbs (1) urges the concave pads (4) towards the soft tissue within the nasal cavity that surrounds the ostium internum.
A further embodiment of the nasal dilator of the present invention can be seen in Figure 7. In this embodiment the deformable bridge (2) is formed from a first and second resiliently deformable u-bend (9)that are connected by a third resiliently deformable u-bend (10), which is inverted in relation to the first and second deformable bridge (10). Thus, the bridge (2) takes the form of an "M".
In the previous two embodiments of the present invention, the configurations permit the dilator to be entirely housed within the nasal cavity.
A further embodiment of the nasal dilator of the present invention can be seen in Figure 8. This embodiment is similar to the embodiment illustrated in Figure 3, but includes a longer limb (11) that extends further than the other two limbs (1). This longer limb (11) includes a tube (12) rotatably mounted around a portion of the longer limb (11). The tube (12) is made from a mesh. In use, the dilator can be inserted into the nostril in much the same manner as described for Figure 3 above, however, the third limb (11) is inserted passed the ostium internum and into the isthmus nasi. When inserted, the tube is positioned in the isthmus nasi and forces the walls of this cavity apart thereby defining a passageway through which air can travel. This is assisted by the outwardly biased limbs (1). The longer limb (11) and the tube (12) are flexible, enabling them to be configured to the shape of the nasal passageway. The tube (12) can move longitudinally and rotate on the third limb (11) so as to be positioned in at the appropriate position along the longer limb (11).
Figure 9 shows a still further embodiment of the present invention with combined spars (3) and grip portions (18). In this embodiment each limb (1) defines a reduced lower limb section (Ia, shown in broken outline) over which cushioned sleeves (20) can be positioned. The cushioned sleeves (20) are moulded out of a soft elastomer and are bonded to the reduced limb sections (Ia) to provide a continuous outer limb surface (22). The cushioned sleeves (20) define a rounded end (24) to assist in easing the dilator into the nasal cavity with minimum discomfort to the wearer. Figure 10 shows an embodiment of the present invention with a notched bridge (2). The bridge (2) of the dilator bends around a notch (26) located at the midpoint of the bridge (2). The bridge (2) also includes opposing kinks (5) which prevent over insertion over the dilator into the nasal cavity. As can be seen from Figure 10, the kinks (5) also define grip portions (18). In this embodiment, the lower ends of the reduced limb portions (Ia) define projections (28). Rather than being moulded separately, cushioned sleeves (20) are moulded over the lower limb portions (Ia), the projections (28) being provided to prevent the cushioned sleeves (20) from slipping off. Figure 11 shows an embodiment of the present invention with a reduced profile. In this embodiment, the bridge (2) is fairly flat so that the dilator can be inserted fully into the nose and worn more discreetly.
When using the above devices, the user will first determine which one of the nasal passageways that is blocked by physically closing one nostril by pinching it with ones fingers and exhaling through the remaining open nasal passageway. If it is difficult to exhale through the open passageway then this passageway is congested. If exhalation is easy then this is the nostril in which the dilator is to be inserted in the above mentioned manner.
The present invention has been described above purely by way of example. It should be understood that modifications in detail may be made within the scope of the invention.

Claims

Claims
1) A nasal dilator comprising at least two opposing limbs that are biased apart and that are configured so as to be capable of being inserted simultaneously into a single nostril.
2) A nasal dilator as claimed in claim 1, that is configured such that once said limbs are inserted they may perform an outward dilation of the nostril at the soft tissue surrounding the ostium internum.
3) A nasal dilator as claimed in any of the preceding claims, wherein the opposing limbs are connected by a resiliently deformable bridge.
4) A nasal dilator as claimed in claim 3, wherein the dilator is moulded so as to form at least two opposing limbs connected by the deformable bridge
5) A nasal dilator as claimed in claim 3, formed from a length of material comprising a notch, around which the length of material may be bent so as to form the resiliently deformable bridge with the lengths of material extending from the notch defining the limbs.
6) A nasal dilator as claimed in any of claims 3 to 5, wherein the thickness of the limbs taper from the thickest point at the bridge.
7) A nasal dilator as claimed in any of the preceding claims, further comprising a cushioned portion provided on each limb.
8) A nasal dilator as claimed in claim 7, wherein the cushioned portion is provided at or towards the end of each limb that are furthermost removed from the bridge.
9) A nasal dilator as claimed in claims 7 or claim 8, wherein the cushioned portion takes the form of a concaved pad. 10) A nasal dilator as claimed in any of claims 7 to 9, or claim 8, wherein the cushioned portion is provided on a stalk that laterally extends from the end of the limb that is furthest removed from the bridge.
11) A nasal dilator as claimed in any of claims 7 to 9, the preceding claims, further comprising at least one stop means associated with at least one limb and configured such that the dilator cannot be inserted into the nasal cavity passed the stop means.
12) A nasal dilator as claimed in claim 11, wherein at least one stop means extends laterally from at least one limb.
13) A nasal dilator as claimed in claim 11 or claim 12, wherein at least one stop ! means is formed integrally with the at least one limb.
14) A nasal dilator as claimed in claim 13, wherein the stop means if formed form a laterally extending kink in at least one limb.
15) A nasal dilator as claimed in any of claims 12 to 14, wherein the stop means extends more than 1 cm from the limb.
16) A nasal dilator as claimed in any of the preceding claims, wherein each limb is more than 1, 1.5, 2 or 2.5 cm in length.
17) A nasal dilator as claimed in any of claims 11 to 16, wherein each limb extends more than 1.5, 2 or 2.5 cm from the stop means to the end of each limb that is further removed from the bridge.
18) A nasal dilator as claimed in any of the preceding claims, wherein all limbs are of equal length.
19) A nasal dilator as claimed in any of the preceding claims, wherein each limb is less than 0.3, 0.25, 0.2 or 0.1 cm thick. 20) A nasal dilator as claimed in any of the preceding claims, wherein at least one limb includes an elbow bend.
21) A nasal dilator as claimed in claim 20, wherein the elbow defines an angle in the limb of substantially 90°.
22) A nasal dilator as claimed in claims 20 or 21, wherein the same elbow bend is provided in all limbs.
23) A nasal dilator as claimed in any of the preceding claims, comprising 2, 3, 4, 5 or more limbs.
24) A nasal dilator as claimed in claim 23, wherein all limbs is equally biased away from each limb.
25) A nasal dilator as claimed in any of the preceding claims, wherein the limbs and resiliently deformable bridge are configured, when in use, so as to be entirely housed within the nasal cavity.
26) A nasal dilator as claimed in claim 25, wherein the resiliently deformable bridge takes the form of a horse shoe with each limb extending in a perpendicular manner therefrom.
27) A nasal dilator as claimed in claim 25, wherein the resiliently deformable bridge is formed from a first and second resiliently deformable u-bend that are connected by a third resiliently deformable u-bend, wherein the third resiliently deformable bridge is inverted in relation to the first and second deformable bridge.
28) A nasal dilator as claimed in any of the preceding claims, further comprising a passageway through which air can flow.
29) A nasal dilator as claimed in claim 27, wherein the passageway is associated with a limb. 30) A nasal dilator as claimed in claim 28 or claim 29, wherein the passageway is defined by a tubular member.
31) A nasal dilator as claimed in claim 30, wherein the tubular member is moveably retained on a limb.
32) A nasal dilator as claimed in claim 30 or claim 31, wherein the tubular member is formed from a mesh.
33) A nasal dilator as claimed in any of claims 29 to 32, wherein the limb associated with the passageway extends further into the nasal cavity than the other limbs.
34) A nasal dilator as claimed in claim 28, wherein the passageway is attached to the bridge.
35) A nasal dilator as claimed in any of claims 31 to 35, wherein the passageway is rotatably mounted.
36) A nasal dilator as claimed in any of claims 28 to 35, wherein the passageway and/or limb associated with the passageway is made of a flexible material.
37) A nasal dilator as claimed in any of the preceding claims, wherein the dilator is disposable.
38) A nasal dilator as claimed in any of the preceding claims that is less than 1 g in weight.
39) A nasal dilator as claimed in any of the preceding claims that is less than 0.5 g in weight.
40) A nasal dilator as claimed in any of the preceding claims that is less than 0.25 g in weight. 41) A nasal dilator as claimed in any of the preceding claims that is made of a synthetic plastics.
42) A nasal dilator as claimed in claim 35 that is made from nylon, polyethylene, polypropylene, or any combination thereof.
43) A nasal dilator as claimed in any of claims 11 to 15, wherein the at least one stop means comprises a grip portion.
44) A nasal dilator as claimed in either of claims 7 or 8, wherein the stalk is of reduced thickness to the rest of the limb so that the outer surface of the limb and the cushioned portion can be continuous
45) A nasal dilator as claimed in either of claims 7 or 8, wherein the cushioned portion is a sleeve.
46) A nasal dilator as claimed in any of claims 7, 8, 44 or 45, wherein the cushioned portions are bonded to the stalks or limbs.
47) A nasal dilator as claimed in any of claims 7, 8, 44 or 45, wherein the cushioned portions are moulded onto the stalks or limbs.
48) A nasal dilator as claimed in any of claims 7 to 47 when dependent on claim 7, wherein the stalks include a projecting portion to retain the cushioned pads
49) A method of inserting a nasal dilator into a single nostril comprising the steps of urging together opposing limbs of a dilator that comprises at least two biased apart limbs so as to reduce the profile of the dilator, passing all limbs of the reduced profile dilator in through a single nostril, and releasing the limbs such that they spring apart providing an outward dilation of the single nostril.
50) A method as claimed in claim 43, further including a first step of locating the unblocked nostril for inserting the dilator into. 51) A method as claimed in either of claims 43 or 44, wherein there are two limbs.
52) A method as claimed in claim 45, wherein the step of passing the limbs in through a single nostril comprises inserting the limbs such that a plane through the limbs is substantially parallel to the septum.
53) A method as claimed in claim 46, wherein the step of passing the limbs in through a single nostril comprises rotating the nasal dilator such that the plane through the limbs is substantially perpendicular to the septum.
54) A method as claimed in any of claims 43 to 47, wherein once the limbs are released the limbs outwardly dilate a side of the nostril away from the septum.
55) A nasal dilator substantially as hereinbefore described and with reference to Figures 1 to 11.
56) A method substantially as hereinbefore described and with reference to Figures 1 to 11.
EP07732342.6A 2006-04-03 2007-04-03 Nasal dilator Not-in-force EP2007329B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0606669.0A GB0606669D0 (en) 2006-04-03 2006-04-03 Nasal Dilator
PCT/GB2007/001298 WO2007113586A1 (en) 2006-04-03 2007-04-03 Nasal dilator

Publications (2)

Publication Number Publication Date
EP2007329A1 true EP2007329A1 (en) 2008-12-31
EP2007329B1 EP2007329B1 (en) 2013-07-17

Family

ID=36425143

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07732342.6A Not-in-force EP2007329B1 (en) 2006-04-03 2007-04-03 Nasal dilator

Country Status (5)

Country Link
US (1) US20100030252A1 (en)
EP (1) EP2007329B1 (en)
JP (1) JP2009532159A (en)
GB (1) GB0606669D0 (en)
WO (1) WO2007113586A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222359A4 (en) * 2007-12-05 2014-03-12 Svip 7 Llc Devices and methods for treating sleep disordered breathing
CA2761769C (en) 2009-05-15 2018-06-05 Intersect Ent, Inc. Expandable devices and methods therefor
US9381332B2 (en) * 2009-10-30 2016-07-05 Brian Judd Nasal dilator
WO2011108282A1 (en) * 2010-03-05 2011-09-09 株式会社アイ.エス.テイ Clip for a nasal cavity insertion device, and nasal cavity insertion device set provided with said clip
US20110230907A1 (en) * 2010-03-19 2011-09-22 Sinocclusive Llc Arterial tamponade device and method
US20110230829A1 (en) * 2010-03-19 2011-09-22 Fitzgerald Patrick J Arterial Tamponade Device and Method
WO2013073934A1 (en) * 2011-11-14 2013-05-23 Robert Andre Nasal dilator and use thereof
CA2903848C (en) 2013-03-14 2022-03-29 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
CA158527S (en) 2014-03-07 2015-05-18 Seven Dreamers Lab Inc Nasal airway tube
CN106659875B (en) * 2014-03-21 2021-03-19 内绍医疗有限公司 Nasal dilator

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US513458A (en) * 1894-01-23 Nasal expander
US1034123A (en) * 1911-09-15 1912-07-30 Annie C Knowlson Nostril-expander.
US1743993A (en) * 1928-11-26 1930-01-14 Lawrence D Washington Nasal distender
US4120302A (en) * 1976-10-08 1978-10-17 American Hospital Supply Corporation Disposable pads for surgical instruments
FR2419711A1 (en) * 1978-03-13 1979-10-12 Gardin Andre Nostril expanding instrument to permit surgical examination - is U=shaped and elastic and is compressed manually for ease of insertion for withdrawal
US4414977A (en) * 1981-07-20 1983-11-15 Wisconsin Alumni Research Foundation Nasal dilator
US4759365A (en) * 1987-03-27 1988-07-26 Leo Askinazy Spring coil wire device
US5816241A (en) * 1995-09-29 1998-10-06 Cook; Lori Irene Coiled nasal dilator
US5931852A (en) * 1997-06-04 1999-08-03 Brennan; H. George Nose airway device
US6270512B1 (en) * 1998-01-22 2001-08-07 Jean V Rittmann Internal nasal dilator
US6626172B1 (en) * 1998-04-30 2003-09-30 Eva-Maria Karow Device for insertion into the human nose
ES1040491Y (en) * 1998-05-22 1999-08-16 Guerra Navas Antonio NASAL ANATOMIC DEVICE TO EXPAND THE RESPIRATORY CAPACITY.
US7390331B2 (en) * 2001-05-22 2008-06-24 Sanostec Corp Nasal inserts
FR2872054B1 (en) * 2004-06-28 2007-03-02 Alexandre Yazdi NASAL DILATOR

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007113586A1 *

Also Published As

Publication number Publication date
GB0606669D0 (en) 2006-05-10
WO2007113586A1 (en) 2007-10-11
US20100030252A1 (en) 2010-02-04
JP2009532159A (en) 2009-09-10
EP2007329B1 (en) 2013-07-17

Similar Documents

Publication Publication Date Title
EP2007329B1 (en) Nasal dilator
US6386197B1 (en) Nasal air passageway opening device
US4414977A (en) Nasal dilator
US10085873B2 (en) Nasal congestion and obstruction relief and breathing assist devices
EP2112937B1 (en) Nasal interface
AU2005266235B2 (en) Nasal dilator and uses thereof
JP7346619B2 (en) Headgear for patient interface
CA2872390C (en) Valved nasal cannula
US20190167464A1 (en) Nasal dilator apparatus
ES2620278T3 (en) Nasal dilator
KR100912498B1 (en) Device for preventing opening mouth during the sleep
US8277477B2 (en) Mechanically deployable upper airway stent
US20060266367A1 (en) Nasal dilator
US20080178888A1 (en) Oral Device
KR101969677B1 (en) A mask for nose with nasal dilators
EP2734149B1 (en) Devices and methods for treating sleep disordered breathing
AU765265B2 (en) An improved breathing assistance apparatus
JP2018501918A (en) Gas delivery device
WO2012127193A1 (en) Breathing device
US20160235577A1 (en) Nasal dilator
EP1175189A1 (en) Device for improving respiration and for eliminating snoring
US20210307951A1 (en) Bi-flow nasal stent
KR20090022709A (en) Prosthesis for preventing snoring and the method for preventing snoring
KR20220090114A (en) Nasal cavity dilator
WO2012066464A2 (en) Oropharyngeal airway support assembly

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081031

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17Q First examination report despatched

Effective date: 20100128

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 621695

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130815

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602007031693

Country of ref document: DE

Effective date: 20130912

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 621695

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130717

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131118

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131117

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130619

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131028

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131018

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

26N No opposition filed

Effective date: 20140422

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602007031693

Country of ref document: DE

Effective date: 20140422

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20141101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140403

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141101

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20150129

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20070403

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130717

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160403

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190225

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20190227

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20200217

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602007031693

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201103

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20210403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210403